The Research Center for Respiratory Diseases (CEPR) is an academic laboratory comprising 4 teams situated in Tours, France, within the shared campus of the Faculty of Medicine and the Bretonneau University Hospital (CHU).
CEPR focuses on elucidating the molecular and cellular mechanisms underlying inflammatory and infectious respiratory diseases. Our main research themes include antimicrobial immunity, proteolytic mechanisms in inflammation, medicinal chemistry and inhaled therapies for respiratory diseases.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 10, Boulevard Tonnellé, Tours,centre-Val De Loire 37000,france
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://cepr-inserm.fr/
- HQ
- Tours, Centre-Val de Loire
- Competitors
- Unité INSERM U1259 - MAVIVHe, Antih Lab, Réseau Français des Centres Régionaux de Pharmacovigilance, Dynafor research lab, GRISOF Groupe de Réflexion et d'Information en Science Ouverte Francophone, Société Francaise de Pharmacologie et de Thérapeutique, Clinaxel, Biose Industrie, Drug Research Center, INSERM.
Cepr Inserm Lab Questions
Cepr Inserm Lab's website is https://cepr-inserm.fr/
Cepr Inserm Lab's LinkedIn profile is https://fr.linkedin.com/company/cepr-inserm-lab
Cepr Inserm Lab has
5 employees.
View email and phone details for 5
employees at Cepr Inserm Lab.
Cepr Inserm Lab's industry is
Research Services
Cepr Inserm Lab's top competitors are
Unité Inserm U1259 - Mavivhe,
Antih Lab,
Réseau Français Des Centres Régionaux De Pharmacovigilance,
Dynafor Research Lab,
Grisof Groupe De Réflexion Et D'information En Science Ouverte Francophone,
Société Francaise De Pharmacologie Et De Thérapeutique,
Clinaxel,
Biose Industrie,
Drug Research Center,
Inserm.
Cepr Inserm Lab's categories are Research Services
Cepr Inserm Lab's founding year is 2012
